美国 · 股市与财经 · Yahoo Finance

Where Will Eli Lilly Stock Be in 5 Years? Follow the Pipeline Beyond Zepbound

来源：Yahoo Finance · 美国 9 小时前

Continue » Eli Lilly's Zepbound is currently the leading medicine in the anti-obesity market largely because it is more effective than its main competitor, Novo Nordisk 's (NYSE:…

在 Yahoo Finance 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finance.yahoo.com)

Where Will Eli Lilly Stock Be in 5 Years? Follow the Pipeline Beyond Zepbound

推荐阅读

David Robinson says a sense of 'cognitive dissonance' led him to leave OpenAI

The 5 most expensive basketball cards ever sold

Wall Street closed in the red as investors focused on yields and the Fed minutes

Global Diesel Crunch Fuels New Wave of Energy Nationalism

Tether Signs Deal With Kazakhstan's Central Bank to Explore a Stablecoin and Tokenized Assets

Apollo, banks in talks to finance SpaceX's $40 billion Nvidia GPU purchase

Where Will Eli Lilly Stock Be in 5 Years? Follow the Pipeline Beyond Zepbound

分享

推荐阅读

David Robinson says a sense of 'cognitive dissonance' led him to leave OpenAI

The 5 most expensive basketball cards ever sold

Wall Street closed in the red as investors focused on yields and the Fed minutes

Global Diesel Crunch Fuels New Wave of Energy Nationalism

Tether Signs Deal With Kazakhstan's Central Bank to Explore a Stablecoin and Tokenized Assets

Apollo, banks in talks to finance SpaceX's $40 billion Nvidia GPU purchase